Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Conditions

• Acquired Bleeding Disorder
• Trauma

Interventions

• DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S